Status:

UNKNOWN

Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction

Lead Sponsor:

Jun Li

Conditions:

Heart Failure

Myocardial Infarction

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

To elucidate the efficacy and safety of weixin decoction in the treatment of heart failure after myocardial infarction.

Detailed Description

To elucidate the long-term protective effect of flavored Wenxin Decoction on heart failure after myocardial infarction. To elucidate the effective components in the treatment of heart failure and the...

Eligibility Criteria

Inclusion

  • 18-75 years old;
  • A history of acute myocardial infarction;
  • Cardiac function Ⅱ - Ⅲ level;
  • LVEF 50% or less;
  • Nt-probnp level ≥ 450 pg/ mL;
  • All men and women can sign the informed consent form.

Exclusion

  • Coronary artery bypass grafting was performed within 12 weeks;
  • Undergo or possibly undergo cardiac resynchronization therapy;
  • Primary valvular disease, left ventricular outflow tract obstruction, myocarditis, aneurysm, uncontrolled severe arrhythmia, cardiogenic shock, unstable angina pectoris, or acute myocardial infarction;
  • Having a serious primary liver, kidney or blood system disease or having a serious mental illness or a systemic disease that is out of control;
  • Serum creatinine \> 194.5 mol/L or serum potassium \> 5.5mmol /L;
  • The level of alanine aminotransferase or alkaline phosphatase is 1.5 times of the normal upper limit of \>;
  • Abnormal blood pressure control, systolic blood pressure exceeding 180mmHg or diastolic blood pressure exceeding 110mmHg;
  • Pregnancy or lactation; Known or suspected allergy to research drugs; To receive another investigational drug within 30 days of randomization or to be unwilling or unable to provide written consent.

Key Trial Info

Start Date :

December 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04667598

Start Date

December 15 2020

End Date

June 30 2023

Last Update

December 14 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.